The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Chronic Administration of Statins Alters Multiple Gene Expression Patterns in Mouse Cerebral Cortex
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Association of apolipoprotein E allele ϵ4 with late‐onset familial and sporadic Alzheimer's disease
Saunders, A. M., Strittmatter, W. J., Schmechel, D., St. George-Hyslop, P. H., Pericak-Vance, M. A., Joo, S. H., Rosi, B. L., Gusella, J. F., Crapper-MacLachlan, D. R., Alberts, M. J., et al. (1993) · Neurology · doi:10.1212/wnl.43.8.1467 · Cited by 3,786
Law, M. R., Wald, N. J., & Rudnicka, A. R. (2003) · BMJ · doi:10.1136/bmj.326.7404.1423 · Cited by 1,720 · cited 2×
“simvastatin is the differences in efficacy of lowering LDL cholesterol levels with simvastatin being more potent (Law et al., 2003).”
BackgroundAllan Butterfield, D. (2002) · Free Radical Research · doi:10.1080/1071576021000049890 · Cited by 786
Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke
Chen, J., Zhang, Z. G., Li, Y., Wang, Y., Wang, L., Jiang, H., Zhang, C., Lu, M., Katakowski, M., Feldkamp, C. S., et al. (2003) · Annals of Neurology · doi:10.1002/ana.10555 · Cited by 538 · cited 1×
“In an experimental model of stroke, brain tissue of rats treated with either simvastatin or atorvastatin displayed increased synaptogenesis, neurogenesis, and angiogenesis that was cholesterol-independent (Chen et al., 2003).”
BackgroundNilsson, C. L., Brinkmalm, A., Minthon, L., Blennow, K., & Ekman, R. (2001) · Peptides · doi:10.1016/s0196-9781(01)00571-x · Cited by 79 · cited 1×
“NPY receptor densities and NPY levels were reported to be decreased in AD brains and cerebrospinal fluid (Martel et al., 1990; Nilsson et al., 2001).”
Background
Cited by
Haag, M. D. M., Hofman, A., Koudstaal, P. J., Stricker, B. H. C., & Breteler, M. M. B. (2009) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2008.150433 · Cited by 393
Statins: Mechanisms of neuroprotection
van der Most, P. J., Dolga, A. M., Nijholt, I. M., Luiten, P. G. M., & Eisel, U. L. M. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.02.002 · Cited by 268
“Only one study did find changes in the cholesterol content of the mouse cerebellum, but not the cerebral cortex (Johnson-Anuna et al., 2005).”
Müller, W. E., Eckert, A., Kurz, C., Eckert, G. P., & Leuner, K. (2010) · Molecular Neurobiology · doi:10.1007/s12035-010-8141-5 · Cited by 243
Self-citationStatins Reduce Amyloid-β Production through Inhibition of Protein Isoprenylation
Ostrowski, S. M., Wilkinson, B. L., Golde, T. E., & Landreth, G. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702640200 · Cited by 180
Role of Vascular Risk Factors and Vascular Dysfunction in Alzheimer's Disease
Dickstein, D. L., Walsh, J., Brautigam, H., Stockton, S. D., Gandy, S., & Hof, P. R. (2010) · Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20155 · Cited by 155
Statin Therapy Inhibits Remyelination in the Central Nervous System
Miron, V. E., Zehntner, S. P., Kuhlmann, T., Ludwin, S. K., Owens, T., Kennedy, T. E., Bedell, B. J., & Antel, J. P. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.080947 · Cited by 141
Statins and the Brain: More than Lipid Lowering Agents?
Fracassi, A., Marangoni, M., Rosso, P., Pallottini, V., Fioramonti, M., Siteni, S., & Segatto, M. (2018) · Current Neuropharmacology · doi:10.2174/1570159x15666170703101816 · Cited by 116
Cholesterol and statins in Alzheimer’s disease: current controversies.
Fonseca, A. C. R. G., Resende, R., Oliveira, C. R., & Pereira, C. M. F. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2009.09.013 · Cited by 93
Ramirez, C., Tercero, I., Pineda, A., & Burgos, J. S. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-101653 · Cited by 67
HMG-CoA reductase promotes protein prenylation and therefore is indispensible for T-cell survival
Lacher, S. M., Bruttger, J., Kalt, B., Berthelet, J., Rajalingam, K., Wörtge, S., & Waisman, A. (2017) · Cell Death & Disease · doi:10.1038/cddis.2017.221 · Cited by 58
Statins and their influence on brain cholesterol
Cibičková, L. (2011) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2011.06.007 · Cited by 58
Statins: drugs for Alzheimer’s disease?
Eckert, G. P., Wood, W. G., & Müller, W. E. (2005) · Journal of Neural Transmission · doi:10.1007/s00702-004-0273-1 · Cited by 46
Self-citationLovastatin, Not Simvastatin, Corrects Core Phenotypes in the Fragile X Mouse Model
Muscas, M., Louros, S. R., & Osterweil, E. K. (2019) · eneuro · doi:10.1523/eneuro.0097-19.2019 · Cited by 30
Rimpelová, S., Kolář, M., Strnad, H., Ruml, T., Vítek, L., & Gbelcová, H. (2021) · Molecules · doi:10.3390/molecules26123528 · Cited by 8
“On the other hand, it significantly increased the expression of the oncogene c-myc and antiapoptotic gene Bcl-2 [84,85].”
BackgroundResultInfluentialHighly variable biological effects of statins on cancer, non-cancer, and stem cells in vitro
Gbelcová, H., Rimpelová, S., Jariabková, A., Macášek, P., Priščáková, P., Ruml, T., Šáchová, J., Kubovčiak, J., Kolář, M., & Vítek, L. (2024) · Scientific Reports · doi:10.1038/s41598-024-62615-w · Cited by 4
“Studies investigating changes in gene expression induced by statin treatment using microarray technology have been published since 2000 25,26 .”
Method
Metadata
- Authors
- Johnson-Anuna, L. N., Eckert, G. P., Keller, J. H., Igbavboa, U., Franke, C., Fechner, T., Schubert-Zsilavecz, M., Karas, M., Müller, W. E., & Wood, W. G.
- Venue
- The Journal of Pharmacology and Experimental Therapeutics
- Publisher
- Elsevier BV
- Published
- 2005-02
- Volume
- 312
- Issue
- 2
- Pages
- 786-793
- ISSN
- 0022-3565 (ISSN-L)
- OpenAlex
- W2084604930
- Cited by
- 201
- References
- 5
- FWCI
- 9.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.